Thyroid receptor ligands

The present invention relates to novel compounds of the thyroid receptor ligands, and the thyroid hormone receptor beta preferentially selective for the general formula (TR-Beta) (I). The present invention also relates to a method of using the said compounds, their tautomeric forms, novel intermediates, methods for preparing acceptable salts its pharmaceutically, the compounds and pharmaceutical compositions containing them which is involved in their synthesis.